Estimated Infection and Vaccine Induced SARS-CoV-2 Seroprevalence in Israel among Adults, January 2020–July 2021

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Israel in February 2020 and spread from then. In December 2020, the FDA approved an emergency use authorization of the Pfizer-BioNTech vaccine, and on 20 December, an immunization campaign began among adults in Israel. We charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Bassal, Ravit, Keinan-Boker, Lital, Cohen, Dani, Mendelson, Ella, Lustig, Yaniv, Indenbaum, Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609359/
https://www.ncbi.nlm.nih.gov/pubmed/36298527
http://dx.doi.org/10.3390/vaccines10101663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609359/
https://www.ncbi.nlm.nih.gov/pubmed/36298527
http://dx.doi.org/10.3390/vaccines10101663

Ejemplares similares